Mono-Femara

MONO-FEMARA BY BELIGAS PHARMACEUTICALS

Tablets

DRUG COMPOSITION

1 tablet contains:
- active substance: letrozole 2.5 mg;
- auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

Aromatase Inhibitor; Antiestrogen.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 2 Days
Routes of administration: by mouth
Dosage forms: (Men): 0.5-2.5 mg/day; (Women): -
Acne: no
Water retention: no
High blood pressure: no
Hepatotoxicity: no
Aromatase: no
Decreased HPTA function (own testosterone production): none
Anabolic activity: Not a steroid
Androgenic activity: Not a steroid
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

2.5 mg tablets.
50 tablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

Beligas Pharmaceuticals
Belgium